OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
David Cabañero, Elena Martín‐García, Rafaël Maldonado
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 8, pp. 659-676
Closed Access | Times Cited: 16
David Cabañero, Elena Martín‐García, Rafaël Maldonado
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 8, pp. 659-676
Closed Access | Times Cited: 16
Showing 16 citing articles:
Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke
Iu Raïch, Jaume Lillo, Rafael Rivas‐Santisteban, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6708-6708
Open Access | Times Cited: 4
Iu Raïch, Jaume Lillo, Rafael Rivas‐Santisteban, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6708-6708
Open Access | Times Cited: 4
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies
Andrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2424-2438
Open Access | Times Cited: 3
Andrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2424-2438
Open Access | Times Cited: 3
Role of CB2 cannabinoid receptor in the development of food addiction in male mice
Alejandra García‐Blanco, Angela Ramírez‐López, Francisco Navarrete, et al.
Neurobiology of Disease (2023) Vol. 179, pp. 106034-106034
Open Access | Times Cited: 8
Alejandra García‐Blanco, Angela Ramírez‐López, Francisco Navarrete, et al.
Neurobiology of Disease (2023) Vol. 179, pp. 106034-106034
Open Access | Times Cited: 8
Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET
Daniel Gündel, Winnie Deuther‐Conrad, Lea Ueberham, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9034-9049
Closed Access | Times Cited: 13
Daniel Gündel, Winnie Deuther‐Conrad, Lea Ueberham, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9034-9049
Closed Access | Times Cited: 13
Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain
Kelsey G. Guenther, Zhili Xu, Julián Romero, et al.
Neuropharmacology (2023) Vol. 237, pp. 109601-109601
Closed Access | Times Cited: 7
Kelsey G. Guenther, Zhili Xu, Julián Romero, et al.
Neuropharmacology (2023) Vol. 237, pp. 109601-109601
Closed Access | Times Cited: 7
Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance
Kelsey G. Guenther, Xiaoyan Lin, Zhili Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116879-116879
Open Access | Times Cited: 2
Kelsey G. Guenther, Xiaoyan Lin, Zhili Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116879-116879
Open Access | Times Cited: 2
Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET
Rodrigo Teodoro, Daniel Gündel, Winnie Deuther‐Conrad, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 13991-14010
Open Access | Times Cited: 6
Rodrigo Teodoro, Daniel Gündel, Winnie Deuther‐Conrad, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 13991-14010
Open Access | Times Cited: 6
Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
Ana Canseco-Alba, Branden Sanabria, Mariam Hammouda, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 9
Ana Canseco-Alba, Branden Sanabria, Mariam Hammouda, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 9
Cannabinoid CB2receptors in primary sensory neurons are implicated in CB2agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance
Kelsey G. Guenther, Xiaoyan Lin, Zhili Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Kelsey G. Guenther, Xiaoyan Lin, Zhili Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats
Kelsey G. Guenther, Jonah L. Wirt, Idaira Oliva, et al.
Neuropharmacology (2024) Vol. 265, pp. 110257-110257
Closed Access | Times Cited: 1
Kelsey G. Guenther, Jonah L. Wirt, Idaira Oliva, et al.
Neuropharmacology (2024) Vol. 265, pp. 110257-110257
Closed Access | Times Cited: 1
New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
Manuel Faundez‐Parraguez, Carlos Alarcón-Miranda, Young Hwa Cho, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11212-11212
Open Access | Times Cited: 10
Manuel Faundez‐Parraguez, Carlos Alarcón-Miranda, Young Hwa Cho, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11212-11212
Open Access | Times Cited: 10
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
Gidion Wilson, Lingling Yang, Xiaojuan Su, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1410-1444
Closed Access | Times Cited: 2
Gidion Wilson, Lingling Yang, Xiaojuan Su, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1410-1444
Closed Access | Times Cited: 2
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist forin vivostudies
Andrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Andrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors
Aaliyah Roberts, Mahli Christian, Lizbeth Nivar Dilone, et al.
Advances in Drug and Alcohol Research (2023) Vol. 3
Open Access
Aaliyah Roberts, Mahli Christian, Lizbeth Nivar Dilone, et al.
Advances in Drug and Alcohol Research (2023) Vol. 3
Open Access
